Literature DB >> 3697945

Lysosomotropic agents reverse multiple drug resistance in human cancer cells.

N Shiraishi, S Akiyama, M Kobayashi, M Kuwano.   

Abstract

Chloroquine, a well-known lysosomotropic amine, partially reversed the resistance of multi-drug-resistant KB carcinoma cells to adriamycin, daunomycin, vincristine, vinblastine and actinomycin D. Other lysosomotropic amines, propranolol, atropine, amantadine and nicotine, also restored the sensitivity of multi-drug-resistant cells to the anticancer drugs. The increased rate of accumulation of [3H] daunomycin by chloroquine was more prominent in the resistant KB-ChR-24 cells than in the parental KB cells. Chloroquine inhibited the efflux of daunomycin from the resistant cells. Circumvention of multiple drug resistance in human KB carcinoma cells by the agents is discussed in relation to lysosomal function.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3697945     DOI: 10.1016/0304-3835(86)90049-2

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  15 in total

1.  Establishment of two new multi-drug resistant variants of the human tumor line Hep-2.

Authors:  A Redmond; E Law; U Gilvarry; M Clynes
Journal:  Cell Biol Toxicol       Date:  1990-07       Impact factor: 6.691

2.  Functional expression of mouse Mdr1 in an outer membrane permeability mutant of Escherichia coli.

Authors:  O Béjà; E Bibi
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

3.  P-glycoprotein mediates drug resistance via a novel mechanism involving lysosomal sequestration.

Authors:  Tetsuo Yamagishi; Sumit Sahni; Danae M Sharp; Akanksha Arvind; Patric J Jansson; Des R Richardson
Journal:  J Biol Chem       Date:  2013-09-23       Impact factor: 5.157

4.  Enhanced lysosomal function is critical for paclitaxel resistance in cancer cells: reversed by artesunate.

Authors:  Zhe Li; Yu-Ting Zhu; Min Xiang; Jun-Lan Qiu; Shou-Qing Luo; Fang Lin
Journal:  Acta Pharmacol Sin       Date:  2020-07-23       Impact factor: 6.150

5.  Effect of calcium antagonists on the chemosensitivity of two multidrug-resistant human tumour cell lines which do not overexpress P-glycoprotein.

Authors:  S P Cole; H F Downes; M L Slovak
Journal:  Br J Cancer       Date:  1989-01       Impact factor: 7.640

6.  Increased plasma membrane traffic in daunorubicin resistant P388 leukaemic cells. Effect of daunorubicin and verapamil.

Authors:  M Sehested; T Skovsgaard; B van Deurs; H Winther-Nielsen
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640

7.  Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agent.

Authors:  Pan Pantziarka; Gauthier Bouche; Vidula Sukhatme; Lydie Meheus; Ilse Rooman; Vikas P Sukhatme
Journal:  Ecancermedicalscience       Date:  2016-10-12

Review 8.  Killing a cancer: what are the alternatives?

Authors:  Peter Kreuzaler; Christine J Watson
Journal:  Nat Rev Cancer       Date:  2012-05-11       Impact factor: 60.716

9.  Synthesis of marmycin A and investigation into its cellular activity.

Authors:  Tatiana Cañeque; Filipe Gomes; Trang Thi Mai; Giovanni Maestri; Max Malacria; Raphaël Rodriguez
Journal:  Nat Chem       Date:  2015-07-20       Impact factor: 24.427

10.  Potentiation of vincristine by vitamin A against drug-resistant mouse leukaemia cells.

Authors:  I Nogae; J Kikuchi; T Yamaguchi; M Nakagawa; N Shiraishi; M Kuwano
Journal:  Br J Cancer       Date:  1987-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.